These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22971537)

  • 1. Screening of blood donors for erythrocyte alloantibodies.
    Pahuja S; Kushwaha S; Sethi N; Pujani M; Jain M
    Hematology; 2012 Sep; 17(5):302-5. PubMed ID: 22971537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of irregular red blood cell antibodies among healthy blood donors in Delhi population.
    Garg N; Sharma T; Singh B
    Transfus Apher Sci; 2014 Jun; 50(3):415-7. PubMed ID: 24797241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell alloantibodies in Lao blood donors.
    Keokhamphoui C; Urwijitaroon Y; Kongphaly D; Thammavong T
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):194-7. PubMed ID: 24964670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO blood group discrepancies among blood donors in Regional Blood Transfusion Centre GTB Hospital, Delhi, India.
    Sharma T; Garg N; Singh B
    Transfus Apher Sci; 2014 Feb; 50(1):75-80. PubMed ID: 24314713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of red blood cell antibodies in whole blood donors: A single-centre experience in north India.
    Solanki A; Chandra T; Singh A
    Indian J Med Res; 2020 Sep; 152(3):280-284. PubMed ID: 33107488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening analysis of irregular antibodies from random donor population in Shaoguan area].
    Zhu JY; Lan JC; Luo HQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):630-1. PubMed ID: 17605881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two robotic platforms to screen plateletpheresis donors for HLA antibodies as part of a transfusion-related acute lung injury mitigation strategy.
    Vassallo RR; Hsu S; Einarson M; Barone J; Brodsky J; Moroff G
    Transfusion; 2010 Aug; 50(8):1766-77. PubMed ID: 20345569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
    Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
    Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of clinically significant antibodies in patients and healthy blood donors: a prospective cross-sectional study from a tertiary healthcare center in India.
    Tiwari AK; Pandey P; Sharma J; Shailja K; Dixit S; Raina V
    Transfus Apher Sci; 2014 Apr; 50(2):230-4. PubMed ID: 24548676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evanescence and persistence of RBC alloantibodies in blood donors.
    Hauser RG; Esserman D; Karafin MS; Tan S; Balbuena-Merle R; Spencer BR; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Gottschall JL; Hendrickson JE; Tormey CA;
    Transfusion; 2020 Apr; 60(4):831-839. PubMed ID: 32061102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automatic Marsh method for detection and identification of erythrocyte antibodies in patients and blood donors.
    Michael-Araszkiewicz P; Maślanka K; Kuśnierz G
    Arch Immunol Ther Exp (Warsz); 1980; 28(2):219-24. PubMed ID: 6778450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for RBC alloantibodies in blood donors in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III).
    Karafin MS; Tan S; Tormey CA; Spencer BR; Hauser RG; Norris PJ; Roubinian NH; Wu Y; Triulzi DJ; Kleinman S; Gottschall JL; Hendrickson JE
    Transfusion; 2019 Jan; 59(1):217-225. PubMed ID: 30427537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of irregular red cell antibody in healthy blood donors attending a tertiary care hospital in North India.
    Makroo RN; Rajput S; Agarwal S; Chowdhry M; Prakash B; Karna P
    Asian J Transfus Sci; 2018; 12(1):17-20. PubMed ID: 29563670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody screening in multitransfused patients: a prerequisite before each transfusion.
    Lamba DS; Mittal K; Sood T; Bedi RK; Kaur P; Kaur G
    Transfus Apher Sci; 2014 Oct; 51(2):132-3. PubMed ID: 25294114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Observations on antibody determination and differentiation with papain test erythrocytes using the gel centrifugation technique (ID-Microtyping System)].
    Strobel E; Wüllenweber J
    Infusionsther Transfusionsmed; 1995 Feb; 22(1):25-30. PubMed ID: 7727960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of irregular red cell alloantibodies in patients with thalassemia major: a bicenter study.
    Bilwani F; Kakepoto GN; Adil SN; Usman M; Hassan F; Khurshid M
    J Pak Med Assoc; 2005 Dec; 55(12):563-5. PubMed ID: 16438282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi
    Yang CA; Lin JA; Chang CW; Wu KH; Yeh SP; Ho CM; Chang JG
    Transfus Med; 2016 Oct; 26(5):349-354. PubMed ID: 27634577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.